Related Experiment Video
Updated: Jan 14, 2026
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Do people want to talk to a doctor about multicancer detection testing? Findings from a National Survey
1College of Public Health, The Ohio State University, Columbus, OH, USA; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Objective:
Healthcare providers may begin encountering more questions and discussions about multicancer detection (MCD) testing from patients. We determined people's communication and decision-making preferences about MCD testing.
Methods:
We conducted an online survey in September 2024 with adults ages 45-80 from the United States (n = 1043). Logistic regression identified correlates of interest in talking to a doctor about MCD testing.
Results:
Overall, 75.5 % of participants wanted to talk to a doctor about MCD testing. Participants with at least a college degree (OR=2.56, 95 % CI: 1.21-5.40) or health insurance (OR=3.39, 95 % CI: 1.84-6.27) were more likely to want to talk to a doctor. Participants wanted to talk to a doctor about how well MCD testing works (63.9 %), cost/insurance coverage (61.9 %), and possible follow-up tests (51.7 %). Most participants (69.5 %) preferred to have a doctor play some role in their final decision about whether or not to have an MCD test, with 30.5 % preferring to make the decision on their own.
Conclusions:
Interest in talking to a doctor about MCD testing is high, and healthcare providers will play a key role in patients' testing decisions.
Practice Implications:
Our findings can inform future education and communication skills training programs for healthcare providers about MCD testing.
More Related Videos
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
05:49Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
Published on: October 10, 2019
Related Concept Videos
02:59Cancer Prevention
Some...
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...